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Abstract The venom of Bungarusfasciatus, an Elapidae snake, 
contains a high level of AChE activity. Partial peptide sequences 
show that it is closely homologous to other AChEs. Bungarus 
venom AChE is a non-amphiphilic monomeric species, a 
molecular form of AChE which has not been previously found 
in significant levels in other tissues. The composition of 
carbohydrates suggests the presence of N-glycans of the 
'complex' and 'hybrid' types. Ion exchange chromatography, 
isoelectric focusing and electrophoresis in non-denaturing and 
denaturing conditions reveal a complex microheterogeneity of
this enzyme, which is partly related to its glyeosylation. 
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1. Introduction 
2. Materials and methods 
2.1. Materials 
Bungarus fasciatus venom was from the stock of Institut Pasteur. 
Reagents for polyacrylamide gel electrophoresis (PAGE), electrofo- 
cusing and Mono Q column were from Pharmacia (Uppsala, Sweden). 
All salts and other reagents were from Merck (Darmstadt, Germany) 
or from Prolabo (Paris, France). Phosphatidylinositol specific phos- 
pholipase C (PI-PLC) from Bacillus thuringiensis was from Immuno- 
tech (Marseilles, France) and neuraminidase from Arthrobacter urea- 
faciens was from Boehringer (Mannheim, Germany). N-Glycanase 
from Flavobacterium eningosepticum was from Genzyme (Boston, 
MA, USA). 
2.2. AChE assay 
AChE activity was determined by the colorimetric method of [6], 
using acetylthiocholine, propionylthiocholine or butyrylthiocholine as 
substrate. Unless otherwise specified, the assay medium contained 
0.75 mM acetylthiocholine iodide, 0.25 mM dithio-bis-dinitrobenzoic 
acid, 0.01 M sodium phosphate, pH 7.4, and the reaction was mon- 
itored at 412 nm. 
Acetylcholinesterase (ACHE, E.C. 3.1.1.7) plays a vital role 
in cholinergic transmission, ensuring an extremely rapid hy- 
drolysis of the neurotransmitter acetylcholine. AChE exists in 
oligomeric forms, which are integrated in various ways in 
cholinergic synapses, in the nervous system and muscles [1]. 
AChE also occurs in non-cholinergic tissues, e.g. in blood cells 
[21. 
The venoms of some Elapid snakes constitute a remarkable 
source of 'non-cholinergic' AChE [3]. In particular, AChE 
may be purified in significant quantities from the venom of 
Bungarus fasciatus. In this report, we show that this enzyme 
presents a strong sequence homology with AChEs from var- 
ious invertebrate and vertebrate species, in agreement with 
previous studies on AChE from the venom of Naja naja oxi- 
ana [4,5]. It differs, however, from AChEs from other verte- 
brate tissues by the fact that it consists entirely of soluble, 
non-amphiphilic monomers. In an attempt to understand 
the significance of AChE in venoms, we analyzed whether it 
was toxic by itself, or acted synergistically with other venom 
components. 
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2.3. Purification of ACHE, sedimentation a d electrophoretic analyses 
Lyophilized Bungarus venom was solubilized in 0.1 M sodium phos- 
phate buffer, pH 7.4 (100 mg/ml), under gentle stirring. An affinity gel 
for AChE was prepared by coupling Sepharose 4B to an m-carboxy- 
phenyldimethylethyl ligand, as previously described [7]. The reconsti- 
tuted venom (2 ml) was applied to 2 ml of affinity gel, equilibrated in
the same buffer (fixation buffer). The column was washed with 10 ml 
of the fixation buffer, 10 ml of buffer complemented with 0.25 M 
NaC1, and finally eluted with 0.1 M sodium phosphate, 0.4 M 
NaC1, 0.02 M decamethonium bromide. Active fractions were pooled 
(affinity purified ACHE) and extensively dialyzed, for 72 h, at 4°C, 
against several changes of 0.1 M sodium phosphate pH 7.4. 
Sedimentation i sucrose gradients, without detergent or in the 
presence of 1% Triton X-100 or Brij-96, was performed as described 
previously (Bon et al., 1988). Isoelectric focusing (IEF) in polyacryl- 
amide gels between pH 3 and pH 9 was performed in a Phastsystem 
apparatus (LKB Pharmacia, Uppsala, Sweden). Gels were fixed with 
20% trichloroacetic a id, stained in methanol/acetic a id/water (31116) 
containing 0.02% Coomassie brilliant blue R and 0.1% CaSO4, and 
destained in the same solution. Polyacrylamide gel electrophoresis 
(PAGE) in denaturing and in non-denaturing conditions was per- 
formed as previously described [8]. AChE activity was revealed by 
the method of [9]. 
2.4. Peptide sequencing 
Tryptic peptides were obtained after trypsin digestion of affinity 
purified AChE from Bungarus venom. They were purified by on-line 
reverse phase HPLC in a Cs column and sequenced by Edman de- 
gradation with an Applied Biosystem 102-A analyzer. 
2.5. Determination of carbohydrate composition 
For the determination f neutral monosaccharides, 4-20 lag of affi- 
nity purified Bungarus venom AChE was mixed with 400 lal of 2 M 
trifluoroacetic acid and incubated at 100°C for 5 h. For basic mono- 
saccharides, hydrolysis of a similar sample was performed with 6 N 
HC1, under the same conditions. For N-acetylneuraminic acid, 0.15 
mg of AChE was digested with neuraminidase from Arthrobacter 
ureafaciens for 15 h at 37°C, in 50 mM sodium acetate buffer pH 
All rights reserved. 
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5.5, in the presence of 0.5 mg/ml bovine serum albumin. In all cases, 
the reaction medium was evaporated to dryness. After addition of 
HO and filtration through a membrane of 0.45 l, tm pore size, an 
aliquot was analyzed by HPLC with a Bio LC Dionex chromatograph 
in a basic Carbopac PAl column (Q54 mm, length 250 mm) using 
gradient elution with sodium hydroxide for monosaccharides, and 
isocratic elution with sodium acetate for neuraminic acid. Three in- 
dependent assays were performed for neutral and basic monosaccha- 
rides, and two for sialic acid. Although glucose was found in some 
a,~ays of neutral sugars, this was erratic and most likely resulted from 
c~,ntamination, as frequently observed. Otherwise, the results howed 
h~gh reproducibility, with less than 5% variation for glucose, man- 
n, ,se, N-acetylglucosamine and sialic acid, and fair reproducibility 
f ir galactose, with about 12% variation. 
2 ~. Fractionation of affinity purified Bungarus venom AChE by ion 
exchange chromatography on a Mono-Q column 
A sample (1 ml) of affinity purified AChE was dialyzed against 25 
n M Tris-HC1 pH 7.5 containing 25 mM MgC12, then applied to a 
Mono Q column (HR 5/5, about 0.4 ml), previously equilibrated with 
tl~,e same buffer. Elution was carried out at a flow rate of 1 ml/min, 
fi:st with a small volume of buffer (isocratic elution), then with a 
li~ear NaC1 gradient from 0 to 0.5 M. Fractions (1 ml) were collected 
il assay tubes containing 0.l ml of 1 mg/ml bacitracin, to prevent 
a, [sorption of the enzyme to the tube walls. 
2 7. Treatment with neuraminidase and PI-PLC 
Neuraminidase-treated ACHE, obtained as described in Section 2.6, 
as subjected to chromatography on a Mono Q column. For IEF, 20 
la samples of 1.5 mg/ml of AChE were incubated with 0.2 mg/ml of 
n,:uraminidase from Clostridium perfringens (Boehringer, Mannheim) 
i~ 50 mM sodium acetate buffer, pH 6.5, for 2 h at 37°C; for non- 
d,'~naturing PAGE, fractions from the Mono Q column were treated 
ith 50 lag/ml neuraminidase, in the same manner. Most of the AChE 
a :tivity was retained after such incubation. Treatment with PI-PLC 
fr 3m Bacillus thuringiensis was performed as previously described [8]. 
Deglycosylation of denatured AChE was performed by N-glycanase 
(~ }enzyme), as specified by the manufacturer, prior to sodium dodecyl 
s Kate PAGE. 
2 8. Toxicity in vivo 
In lethality assays, we used 3 week old male Swiss mice weighing 
1%20 g, from Charles River (St Aubin-l~s-Elbeuf, France). Samples 
" 0.2 ml of Bungarus fasciatus venom or of affinity purified AChE 
~ere injected intravenously. Crude Bungarus fasciatus venom (1 g) 
as dissolved in 20 ml of water. The material which did not adsorb 
t ,  a 2 ml affinity column (see above) was the AChE-depleted venom. 
"1 he purified enzyme, eluted 20 mM decamethonium bromide, was 
e':tensively dialyzed against 20 mM sodium phosphate pH 7.0 con- 
t ining 20 mM NaC1, concentrated by lyophilization, then gel-filtered 
i the same buffer through a Sephadex G-25 column. 
The lethal potency (LDs0) and the confidence limits of LDs0 were 
c tlculated by the statistical method of Spearman-K~rber, as recom- 
r ended by the World Health Organization (World Health Organiza- 
t ~n Bulletin, offset publication No. 58, pp. 25 27, 1981). Three mice 
v ere injected with each dose, and the doses differed by a factor of 
1 414 ((2). 
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Fig. 1. Alignment of partial peptide sequences from Bungarus ve- 
nom AChE with the primary sequence of Torpedo marmorata 
ACHE. Single and double dots indicate similar and identical residues 
between the two enzymes. 
tially no activity on butyrylthiocholine. It also presents an 
excess substrate inhibition, above 3 mM acetylthiocholine. It 
is inhibited by eserine (physostigmine), with an ICa0 of about 
2 × 10 -9 M. This enzyme thus possesses all the characteristics 
of a typical ACHE. 
Bungarus venom AChE could be successfully purified by 
affinity chromatography on m-carboxyphenyldimethylethyl- 
EAH-Sepharose [7], with a yield of 85%, producing 2-5 mg 
AChE/g of dry venom. The N-terminal sequence of affinity 
purified Bungarus venom AChE was blocked, but we deter- 
mined peptide sequences from several tryptic fragments. These 
partial sequences could be aligned with the primary sequence 
of other AChEs (Fig. 1). 
3.2. Macromolecular structure." a non-amphiphilic monomer 
In sucrose gradients, Bungarus AChE sedimented as a 
monodisperse peak of 4.5 S (Fig. 2). The same sedimentation 
was observed with crude venom and with purified AChE and 
was not affected by addition of the non-denatur ing detergents 
Triton X-100 or Brij-96. In gel fi ltration chromatography 
through a Sephadex column, this enzyme eluted at approxi- 
mately the same position as bovine serum albumin, indicating 
that its Stokes radius is close to 4.5 nm. Together, these hy- 
drodynamic analyses indicate that Bungarus venom AChE is a 
non-amphiphi l ic monomeric species. In addition, the affinity 
purified enzyme showed the same pattern in PAGE,  under 
denaturing conditions, with or without reduction. 
3, Results 
5 1. Bungarusfasciatus venom contains a true AChE 
Bungarus venom contains an enzyme which hydrolyzes ace- 
t dthiocholine faster than propionylthiocholine, and has essen- 
3.3. Carbohydrate composition of  Bungarus venom AChE 
Affinity purified Bungarus venom AChE contains about 7% 
of its weight of carbohydrates: 37% mannose, 32% N-acetyl- 
glucosamine, 11% galactose, 9% fucose, 9% N-acetylneurami- 
nic acid, indicating that the protein carries mostly N-glycans 
"1 able 1 
~ ChE does not contribute to the lethal potency of the venom 
i raction Protein LD~0 AChE activity 
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\ alues are means and standard errors of two experiments. 
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Fig. 2. Sedimentation profile of Bungarus venom ACHE. The sedi- 
mentation coefficients were deduced from the positions of the peaks 
of the internal sedimentation standards, catalase (11.3 S) and alka- 
line phosphatase (6.1 S). The sedimentation of AChE was identical 
in the presence of 1% Triton X-100 (A), 1% Brij-96 (11), or in the 
absence of detergent in the gradient medium (©), indicating that the 
Bungarus venom enzyme is a non-amphiphilic species (4.5 S). 
of the 'complex' type; the high proportion of mannose may 
correspond to small amounts of N-glycans of the 'hybrid' type 
[10]. In addition, the presence of a minor component of N- 
acetylgalactosamine (2%) suggests the possible presence of O- 
linked glycans. The amount of neuraminic acid corresponds to
approximately two residues per AChE molecule, on average. 
3.4. Electric charge and microheterogeneity of Bungarus venom 
AChE 
When subjected to exchange chromatography on a Mono Q 
cationic column, affinity purified Bungarus AChE was eluted 
as a small peak (isocratic elution) followed by a broad peak 
(salt gradient elution), suggesting charge heterogeneity (Fig. 
3). 
In PAGE under denaturing conditions, each of the peaks 
eluted from the Mono Q column was found to contain a 
major AChE subunit, around 66-68 kDa (this band migrated 
slightly faster in the case of the more acidic fraction 10 than in 
the case of fraction 4), and a minor one at 63 kDa (Fig. 5A). 
In the affinity purified enzyme, the superposition of the two 
doublets produced a more diffuse pattern. After digestion with 
N-glycanase, all these enzyme fractions yielded the same thin 
band, at 57 kDa, indicating that the heterogeneity of their 
apparent mass was due to differences of their N-glycans. 
Non-denaturing PAGE gave rise to 4-5 bands, and IEF 
also resolved affinity purified AChE into 8-9 distinct bands, 
with pls ranging from 5.2 to 5.8. Analysis of a series of frac- 
tions eluted from the Mono Q column showed that they con- 
tained variable proportions of these bands, according to their 
electric charge (Fig. 4). Clearly, these components were not 
resolved in the chromatographic conditions used in Fig. 3. 
Digestion by neuraminidase r duced the heterogeneity ob- 
served in non-denaturing PAGE and in IEF (Fig. 5B,C). In 
addition, neuraminidase treatment significantly modified the 
elution profile from the Mono Q column, increasing the pro- 
portion of enzyme eluted in the first peak, and shifting the 
second peak towards lower salt concentration (not shown). 
The fact that a large fraction was still eluted at higher ionic 
strength may result from an incomplete removal of sialic 
acids, under our experimental conditions. 
3.5. Lack of toxicity of Bungarus venom AChE 
We examined whether AChE possesses an intrinsic toxicity, 
or reinforces the effect of other venom components. Injection 
of affinity purified ACHE, up to 80 mg/kg, induced no lethal- 
ity, whereas the crude venom killed the mice with an LDs0 of 
about 2.5 mg/kg (Table 1). Moreover, the lethal potency of a 
venom which had been depleted from its AChE was the same 
as that of complete venom. Addition of a large excess of 
purified AChE to depleted venom (4 mg of AChE added to 
1 mg of venom, i.e. 1000 times its original content in ACHE) 
was found to slightly increase its lethal potency (about I0%), 
but this effect could be entirely accounted for by the presence 
of decamethonium, which is used to elute AChE from the 
affinity column, and is not completely eliminated even after 
prolonged ialysis and gel filtration. We did not, therefore, 
observe any synergistic effect of AChE with other venom 
components. 
4.  D iscuss ion  
In this report, we show that the venom of Bungarus fascia- 
tus contains a true ACHE, which presents characteristic cata- 
lytic properties, as first reported by Kumar and Elliott [3]. Its 
molecular mass is similar to that of AChE catalytic subunits 
from Torpedo and mammals, and partial peptide sequences 
establish that its catalytic domain is homologous to that of 
other AChEs. This enzyme is a monomeric, non-amphiphilic 
species, and thus differs from all AChE forms that had pre- 
viously been identified in other tissues. The cloning of Bun- 
garus AChE showed that the venom enzyme corresponds in 
fact to a novel type of subunit [11], possessing a hydrophobic 
C-terminal sequence that differs from those encoded by the 
alternative xons H and T [1]. We found that this enzyme 
remained monomeric, in sucrose gradients, up to 0.2 mg/ml 
at the peak [12]. It is possible that dimers may form at higher 
concentrations, since Raba et al. [13] showed that AChE from 
cobra (Naja naja oxiana) venom was monomeric up to 0.2 mg/ 
ml but reversibly aggregated into dimers around 2 mg/ml, in 
the analytical centrifuge. 
i , 0.6 
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Fig. 3. Chromatography on a Mono Q column: elution profile o f  
AChE activity. The scale shown on the right axis corresponds to 
the NaCI concentration i the elution buffer. 
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Ion exchange chromatography, non-denaturing PAGE and 
IEF revealed a charge heterogeneity of Bungarus venom 
ACHE, with multiple components ranging from pl 5.2 to pI 
58. The effect of neuraminidase showed that this is partly due 
tc its content in sialic acids, in agreement with the fact that 
Bungarus AChE contains 7% carbohydrates, with a character- 
istic composition of N-glycans of the 'complex' and 'hybrid' 
t:pes. A similar heterogeneity was observed for the cobra 
~;:nom AChE [13]. In non-denaturing PAGE, the polydisper- 
sty of this enzyme is remarkably more pronounced than for 
AChEs of other tissues, which have been studied previously 
(,ee for example [14]). We observed a similar polydispersity in
tte case of AChEs from the venoms of other Elapidae snakes, 
Uaja naja, Ophiophagus hanna, Haemachatus haemachates (not 
saown), and also in the case of recombinant Bungarus venom 
ACHE, expressed in COS cells [11], ruling out the hypothesis 
t~lat it would result from differences between individual snakes 
r modifications during storage of the venom. Raba et al. [13] 
t :ported that, in the case of cobra venom ACHE, neuramini- 
~ase digestion modified the isoelectric focusing pattern, but 
cid not abolish the multiplicity of bands, in agreement with 
t ~e present observations. These authors uggested, therefore, 
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£ig. 4. Microheterogeneity of Bungarus venom ACHE, in non-dena- 
:uring PAGE and IEF. Affinity purified ACHE, as well as fractions 
"rom the Mono Q column (Fig. 3) were analyzed (A) by non-dena- 
z:uring PAGE in a 10% polyacrylamide gels and staining of the 
~ChE activity and (B) by IEF, followed by staining of the protein. 
the column fractions which were eluted at higher salt concentration 
were enriched in more negatively charged components. 
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Fig. 5. Effect of N-glycanase and neuraminidase onBungarus venom 
ACHE. Affinity purified AChE and fractions from the minor and 
major peaks, eluted at low and high ionic strength from the Mono 
Q column (Fig. 3) were denatured and analyzed by PAGE in the 
presence of sodium dodecyl sulfate and dithiothreitol, with or with- 
out treatment by N-glycanase, asindicated (A); the effect of neura- 
minidase on active AChE was analyzed in non-denaturing condi- 
tions, by PAGE (B) and by IEF (C). 
that, in addition to glycosylation heterogeneity, charge iso- 
forms may reflect variations in free glutamic or aspartic acids, 
produced by post-translational deamidation of glutamines 
and asparagines [15]. Such a modification may also contribute 
to the heterogeneity of Bungarus venom ACHE, and would 
explain the fact that neuraminidase tr atment did not produce 
a single electrophoretic band. 
The physiological significance, if any, of AChE in snake 
venoms raises an extremely intriguing question. AChE exists 
at high levels in the venom of snakes from four genera of the 
Elapidae family ( Bungarus, Haemachatus, Naja, Ophiophagus), 
but not in the venom of the Dendroaspis genus (mambas), 
which contains the anti-AChE toxin fasciculin (Y. Frobert, 
200 X. Cousin et al./FEBS Letters 387 (1996) 196-200 
X. Cousin, C. Cr6minon, M.-H. R6my, J.-M. Chatel, S. Bon, 
C. Bon and J. Grassi, in preparation). Since the venom of 
Elapidae snakes contains a-toxins which block the nicotinic 
receptor at neuromuscular junctions, it might be thought hat 
AChE synergistically participates in a concerted blockade of 
cholinergic synapses by eliminating acetylcholine. On the 
other hand, this particular enzyme might exert a toxic effect, 
related to its molecular structure rather than to its catalytic 
activity. We found, however, that this enzyme is not toxic to 
mice, even at very high doses, in agreement with previous 
studies [16,17]. Moreover, it did not reinforce the toxicity of 
other venom components. Its presence in snake venoms there- 
fore remains a mystery. 
In any case, because of its relative abundance and original 
properties, this venom enzyme provides an excellent model for 
analyzing the catalytic mechanism of ACHE, in a soluble 
monomeric form. 
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